Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth.
Cleland
John G F
JG
Clark
Andrew L
AL
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D015897:Comorbidity; D004359:Drug Therapy, Combination; D005060:Europe; D006299:Health Services for the Aged; D006333:Heart Failure / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D014481:United States / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists